If you are a Care Partner for someone with Lewy body dementia who is experiencing hallucinations (seeing or otherwise sensing things that are not there) or delusions (believing things that are not true), find out about participating in our research study of an investigational drug for these common symptoms.
The Illumera Study is a study of an investigational drug that is intended to treat psychosis symptoms related to Lewy body dementia in two doses against a placebo (an inactive substance that looks like the investigational drug).
Qualified study participants must:
The study will last about 15 weeks. Those who complete the study may have the option to enter an open-label long-term extension study, in which all participants receive the active study drug and are told at which dose.
To Qualify for The Illumera Study
To see if the person you care for may qualify to participate in our study, please take our pre-qualification questionnaire. If you prequalify based on the answers you provided, you will have the option to submit your contact information to the nearest participating study center.
If you submit your information, the study center staff will contact you to give you more details about the study. You and the person you care for may be asked to come to the study center to undergo additional assessments to determine whether they are eligible for the study. You and the person you care for are not obligated to participate in the study at any point in the process.
Lewy body dementia (LBD) is the second most common form of dementia. The name “Lewy body dementia” is an umbrella term for two diseases: dementia with Lewy bodies, and Parkinson’s disease dementia. In both diseases, problems with thinking, movement, behavior, mood, and other bodily functions are associated with an unusual buildup (also referred to as “abnormal deposits”) of a protein in the brain. These buildups are called “Lewy bodies.”
Although there are some differences, people with either form of Lewy body dementia eventually develop similar symptoms due to the presence of Lewy bodies in the brain.
If problems with thinking begin to occur less than a year after movement symptoms appear, this is called dementia with Lewy bodies.
If movement symptoms begin a year or more before problems with thinking begin, this is called Parkinson’s disease dementia.
Clinical research is crucial for developing new treatments and improving patient care. Without it, many common medicines and treatments would not be available.
A research study (sometimes called “clinical research” or a “clinical trial”) is generally considered to be health-related research in people who have a specific condition. Research studies follow a pre-defined written set of instructions and guidelines (also known as the “protocol”) for how the study is to be conducted.
A copy of the Data Protection and Privacy Policy for this website is available at this location:
Data Protection and Privacy Policy https://tprausa.com/privacy/